Estrogen and tamoxifen up-regulate FXYD3 on breast cancer cells: assessing the differential roles of ER α and ZEB1

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma

(2013) Zhen-Long Zhu et al.   DISEASE MARKERS

δEF1 Down-Regulates ER-α Expression and Confers Tamoxifen Resistance in Breast Cancer

(2012) Shaocong Guo et al.   PLoS One

A MicroRNA196a2* and TP63 Circuit Regulated by Estrogen Receptor-α and ERK2 that Controls Breast Cancer Proliferation and Invasiveness Properties

(2012) Kyuri Kim et al.   Hormones & Cancer

Down-Regulation of FXYD3 Is Induced by Transforming Growth Factor-β Signaling via ZEB1/δEF1 in Human Mammary Epithelial Cells

(2011) Hiroto Yamamoto et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Identification of novel targets for breast cancer by exploring gene switches on a genome scale

(2011) Ming Wu et al.   BMC GENOMICS

Epigenetically Deregulated microRNA-375 Is Involved in a Positive Feedback Loop with Estrogen Receptor   in Breast Cancer Cells

(2010) P. de Souza Rocha Simonini et al.   CANCER RESEARCH

FXYD3 Protein Involved in Tumor Cell Proliferation Is Overproduced in Human Breast Cancer Tissues

(2009) Hiroto Yamamoto et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer

(2008) S. Spaderna et al.   CANCER RESEARCH